1. Home
  2. PHAT vs CPAC Comparison

PHAT vs CPAC Comparison

Compare PHAT & CPAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHAT
  • CPAC
  • Stock Information
  • Founded
  • PHAT 2018
  • CPAC 1949
  • Country
  • PHAT United States
  • CPAC Peru
  • Employees
  • PHAT N/A
  • CPAC N/A
  • Industry
  • PHAT Biotechnology: Pharmaceutical Preparations
  • CPAC Building Materials
  • Sector
  • PHAT Health Care
  • CPAC Industrials
  • Exchange
  • PHAT Nasdaq
  • CPAC Nasdaq
  • Market Cap
  • PHAT 465.0M
  • CPAC 475.3M
  • IPO Year
  • PHAT 2019
  • CPAC 2012
  • Fundamental
  • Price
  • PHAT $5.67
  • CPAC $5.77
  • Analyst Decision
  • PHAT Strong Buy
  • CPAC Sell
  • Analyst Count
  • PHAT 4
  • CPAC 1
  • Target Price
  • PHAT $23.00
  • CPAC $6.00
  • AVG Volume (30 Days)
  • PHAT 1.0M
  • CPAC 5.1K
  • Earning Date
  • PHAT 03-06-2025
  • CPAC 03-04-2025
  • Dividend Yield
  • PHAT N/A
  • CPAC 8.69%
  • EPS Growth
  • PHAT N/A
  • CPAC 17.75
  • EPS
  • PHAT N/A
  • CPAC 0.12
  • Revenue
  • PHAT $26,270,000.00
  • CPAC $524,464,683.00
  • Revenue This Year
  • PHAT $7,453.23
  • CPAC N/A
  • Revenue Next Year
  • PHAT $226.38
  • CPAC N/A
  • P/E Ratio
  • PHAT N/A
  • CPAC $9.19
  • Revenue Growth
  • PHAT N/A
  • CPAC 1.44
  • 52 Week Low
  • PHAT $5.21
  • CPAC $5.10
  • 52 Week High
  • PHAT $19.71
  • CPAC $6.65
  • Technical
  • Relative Strength Index (RSI)
  • PHAT 39.59
  • CPAC 49.77
  • Support Level
  • PHAT $5.50
  • CPAC $5.70
  • Resistance Level
  • PHAT $6.21
  • CPAC $6.00
  • Average True Range (ATR)
  • PHAT 0.40
  • CPAC 0.15
  • MACD
  • PHAT 0.07
  • CPAC -0.01
  • Stochastic Oscillator
  • PHAT 38.69
  • CPAC 31.88

About PHAT Phathom Pharmaceuticals Inc.

Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.

About CPAC Cementos Pacasmayo S.A.A. (Each representing five)

Cementos Pacasmayo SAA is a Peruvian cement company that primarily produces, distributes, and sells cement and cement-related materials, such as concrete blocks and ready-mix concrete. The company's products are primarily used in construction. It also produces and sells quicklime for use in mining operations. The company sells its products mainly in the northern part of Peru. It owns three cement production facilities. Its flagship Pacasmayo facility is located in the northwest region of Peru, while its new cement plant in Piura and smaller Rioja facility are located in the northeast region of Peru.

Share on Social Networks: